Kidswell Bio Corporation (TYO:4584)
Japan flag Japan · Delayed Price · Currency is JPY
141.00
-1.00 (-0.70%)
Nov 18, 2026, 10:18 AM JST

Kidswell Bio Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2022FY 2021FY 2020
Period EndingSep '26 Mar '26 Mar '25 Mar '22 Mar '21 Mar '20
Revenue
5,7886,5895,0821,5699961,077
Revenue Growth
-12.42%29.65%223.90%57.53%-7.52%5.41%
Gross Profit
1,4751,5231,4331,018876423
Operating Income
132-13928-919-970-1,162
Net Income
120-413-21-535-1,001-7,316
Earnings Per Share
2.40-8.46-0.52-17.34-34.77-264.64
EPS Growth
-61.32%-----

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2022FY 2021FY 2020
Period EndingSep '26 Mar '26 Mar '25 Mar '22 Mar '21 Mar '20
Cash & Investments
3,4413,2942,9951,1871,4612,032
Total Debt
2,2742,5491,8377001,1001,225
Net Cash (Debt)
1,1677451,158487361807
Net Cash Growth
186.73%-35.66%137.78%34.90%-55.27%-59.84%
Net Cash Per Share
23.4315.2728.5915.7912.5429.19

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2022FY 2021FY 2020
Period EndingSep '26 Mar '26 Mar '25 Mar '22 Mar '21 Mar '20
Operating Cash Flow
329-1,096936-1,169-1,267-1,325
Capital Expenditures
-17-17-6---1
Free Cash Flow
312-1,113930-1,169-1,267-1,326
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2022FY 2021FY 2020
Period EndingSep '26 Mar '26 Mar '25 Mar '22 Mar '21 Mar '20
Gross Margin
25.48%23.11%28.20%64.88%87.95%39.28%
Operating Margin
2.28%-2.11%0.55%-58.57%-97.39%-107.89%
Pretax Margin
3.97%-6.10%1.44%-34.03%-100.40%-679.11%
Profit Margin
2.07%-6.27%-0.41%-34.10%-100.50%-679.29%
FCF Margin
5.39%-16.89%18.30%-74.51%-127.21%-123.12%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2022FY 2021FY 2020
Period EndingNov '26 Mar '26 Mar '25 Mar '22 Mar '21 Mar '20
Forward PE
5.8114.2515.50---
P/FCF Ratio
23.03-5.18---
PS Ratio
1.241.830.959.2214.9913.45